Compounds > 5-hydroxymethylcytosine
Page last updated: 2024-08-25

5-hydroxymethylcytosine and Prostatic Neoplasms

5-hydroxymethylcytosine has been researched along with Prostatic Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (63.64)24.3611
2020's4 (36.36)2.80

Authors

AuthorsStudies
Ci, W; Huang, C; Qi, J; Shi, Y; Tan, Y; Wang, J; Zhang, J; Zhang, Q1
Aggarwal, R; Alumkal, JJ; Annala, M; Ashworth, A; Beer, TM; Bergamaschi, A; Bjartell, A; Bose, R; Boutros, PC; Chen, S; Chen, WS; Chesner, L; Chi, KN; Chou, J; Cui, XL; Evans, CP; Feng, FY; Fong, L; Foye, A; Fraser, M; Gilbert, LA; Gleave, M; Haffner, MC; He, C; He, HH; Herberts, C; Hua, JT; Huang, FW; Huang, J; Lang, JM; Lara, PN; Levy, S; Li, H; Lloyd, P; Lundberg, A; Luo, J; Mahajan, NP; Maher, CA; Maheshwari, A; Maurice-Dror, C; McCarthy, E; Moreno-Rodriguez, T; Morgans, AK; Ng, SWS; Ning, Y; Perry, MD; Petricca, J; Phillips, T; Posadas, EM; Quigley, DA; Reiter, RE; Rettig, MB; Shrestha, R; Sjöström, M; Small, EJ; Thomas, GV; Tran, PT; Witte, ON; Wyatt, AW; Ye, W; Zhang, M; Zhao, SG; Zoubeidi, A; Zwart, W1
Attard, G; Wu, A1
Arda-Pirincci, P; Caglayan, M; Fatma Karaman, E; Ozal-Coskun, C; Ozden, S; Sancar-Bas, S1
Chen, Z; Fan, M; Feng, Y; Liang, B; Luo, G; Shi, J; Sun, Y; Wang, K; Xu, X; Yu, M; Zhuang, Q1
Claessens, F; Helsen, C; Joniau, S; Lynch, AG; Massie, CE; Moris, L; Prekovic, S; Smeets, E; Van den Broeck, T1
Belengeanu, V; Grelus, A; Ioiart, I; Miklos, I; Nica, DV; Popescu, C1
Borre, M; Høyer, S; Lynnerup, AS; Storebjerg, TM; Strand, SH; Sørensen, KD; Ørntoft, TF1
Berg, KD; Borre, M; Brasso, K; Høyer, S; Kristensen, G; Røder, MA; Strand, SH; Sørensen, KD; Toft, BG1
Fujimura, T; Hayashizaki, Y; Homma, Y; Inoue, S; Misawa, A; Suzuki, T; Takagi, K; Takahashi, S; Takayama, K; Urano, T1
Argani, P; Chaux, A; De Marzo, AM; Esopi, DM; Gerber, J; Haffner, MC; Iacobuzio-Donahue, C; Meeker, AK; Nelson, WG; Netto, GJ; Pellakuru, LG; Toubaji, A; Yegnasubramanian, S1

Reviews

1 review(s) available for 5-hydroxymethylcytosine and Prostatic Neoplasms

ArticleYear
The role of TET-mediated DNA hydroxymethylation in prostate cancer.
    Molecular and cellular endocrinology, 2018, 02-15, Volume: 462, Issue:Pt A

    Topics: 5-Methylcytosine; Animals; DNA Methylation; Epigenesis, Genetic; Humans; Male; Models, Biological; Prostatic Neoplasms; Proto-Oncogene Proteins

2018

Other Studies

10 other study(ies) available for 5-hydroxymethylcytosine and Prostatic Neoplasms

ArticleYear
Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways.
    Clinical epigenetics, 2022, 09-20, Volume: 14, Issue:1

    Topics: 5-Methylcytosine; Ascorbic Acid; Carcinogenesis; DNA; DNA Methylation; Fibrin; Humans; Magnesium; Male; Phosphates; Prostatic Neoplasms; Urogenital Neoplasms

2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
    Cancer research, 2022, 11-02, Volume: 82, Issue:21

    Topics: 5-Methylcytosine; Biopsy; Humans; Male; Prostate; Prostatic Neoplasms

2022
Accidentals of the DNA Symphony.
    Cancer research, 2022, 11-02, Volume: 82, Issue:21

    Topics: DNA; DNA Methylation; Humans; Male; Prostatic Neoplasms

2022
Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells.
    Environmental pollution (Barking, Essex : 1987), 2019, Volume: 255, Issue:Pt 2

    Topics: 5-Methylcytosine; Benzhydryl Compounds; Cell Line, Tumor; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Down-Regulation; Endocrine Disruptors; Epigenesis, Genetic; Gene Expression; Histone Code; Humans; Male; PC-3 Cells; Phenols; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Tissue Inhibitor of Metalloproteinase-3; Tumor Suppressor Proteins

2019
Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
    The Prostate, 2020, Volume: 80, Issue:12

    Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Movement; DNA Methylation; HEK293 Cells; Humans; Male; Mixed Function Oxygenases; Neoplasm Invasiveness; PC-3 Cells; Prostatic Neoplasms; Proto-Oncogene Proteins; Resveratrol; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Up-Regulation

2020
Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study.
    International journal of molecular sciences, 2017, Nov-20, Volume: 18, Issue:11

    Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Humans; Leukocytes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms

2017
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
    Clinical epigenetics, 2018, 08-07, Volume: 10, Issue:1

    Topics: 5-Methylcytosine; Adult; Aged; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Receptors, Estrogen; Tissue Array Analysis

2018
5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors.
    International journal of molecular sciences, 2019, Feb-27, Volume: 20, Issue:5

    Topics: 5-Methylcytosine; Aged; Cohort Studies; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prostatectomy; Prostatic Neoplasms; ROC Curve; Transcriptional Regulator ERG

2019
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
    Nature communications, 2015, Sep-25, Volume: 6

    Topics: 5-Methylcytosine; Aged; Androgens; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cytosine; Dioxygenases; Disease Progression; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hepatocyte Nuclear Factor 3-alpha; Humans; Hydroxylation; Immunohistochemistry; Male; Mice, Inbred BALB C; MicroRNAs; Middle Aged; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, RNA; TOR Serine-Threonine Kinases

2015
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
    Oncotarget, 2011, Volume: 2, Issue:8

    Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differentiation; Colonic Neoplasms; Cytosine; Down-Regulation; Embryo, Mammalian; Female; Gestational Age; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Stem Cells

2011